
Regulatory Considerations in the Design, Development and Quality of Monoclonal Antibodies and Related Novel Antibody-Based Products

Speaker Presentation: CMC Strategy Forum North America 2025
Shapiro Marjorie, CDER, FDA (Retired), 2025
Regulatory Considerations in the Design, Development and Quality of Monoclonal Antibodies and Related Novel Antibody-Based Products